Author

Aidan C.A. Tomlinson

Revolution Medicines (United States)ORCID 0000-0002-9663-773XUnclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Approach:genetic perturbation / CRISPR· 1 Organism:human· 1

Frequent Co-Authors

Adrian Vega· 1 shared Alyna KattiiD· 1 shared Bianca Jay DiaziD· 1 shared Chen ZhangiD· 1 shared Elizabeth Grankowsky· 1 shared Henri SchmidtiD· 1 shared Ida AronchikiD· 1 shared Lukas E. DowiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Adrian Vega

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Genetic mechanisms of resistance to targeted KRAS inhibition

Bianca Jay Diaz, M.S. Kops, Sara Bernardo, Henri Schmidt, Elizabeth Grankowsky, Adrian Vega, Chen Zhang, Matthew Joseph Bott, Maria Skamagki, Aidan C.A. Tomlinson, Nicole A. Vita, Alyna Katti, Mark P. Labrecque, Ida Aronchik, Mallika Singh, Lukas E. Dow

This study identifies genetic mechanisms of resistance to KRAS inhibitors by using CRISPR screens to find resistance mutations and signaling rewiring in NSCLC.

bioRxiv · Aug 4, 2025 · PreprintCancer Biology